1E10 anti-idiotype vaccine

3 trials

Sponsors

Center of Molecular Immunology (CIM)

Conditions

Advanced Lung Cancer Non-small Cell Lung CancerAdvanced Lung Cancer Small Cell Lung CancerBreast carcinoma in stage IV or progressive metastatic disease

Phase 2

1E10 anti-idiotype vaccine, metastatic breast cancer, phase II

Active, not recruitingRPCEC00000008

Center of Molecular Immunology (CIM)Breast carcinoma in stage IV or progressive metastatic disease

Start: 2003-09-15Target: 80Updated: 2026-03-30

Anti-idiotype 1E10 vaccine in advanced non- small cell lung (NSCLC) patients

Active, not recruitingRPCEC00000009

Center of Molecular Immunology (CIM)Advanced Lung Cancer Non-small Cell Lung Cancer

Start: 2006-09-27Target: 176Updated: 2026-03-30

Anti-idiotype 1E10 vaccine in the treatment of patients with small cell lung (SCLC) patients

Active, not recruitingRPCEC00000010

Center of Molecular Immunology (CIM)Advanced Lung Cancer Small Cell Lung Cancer

Start: 2005-03-03Target: 88Updated: 2026-03-30